Dealing with behavioral and psychological symptoms of dementia: A general overview

Psychology Research and Behavior Management

Volumn 8, Issue , 2015, Pages 181-185

  Azermai, Majda ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Behavioral symptoms; Dementia; Interventions; Nonpharmacological intervention; Psychological symptoms

Indexed keywords

EID: 84937001827     PISSN: None     EISSN: 11791578     Source Type: Journal    
DOI: 10.2147/PRBM.S44775     Document Type: Review

References (29)

1. Prince M, Jackson J, editors. World Alzheimer Report. London, UK: Alzheimer Disease International; 2009. Available from: http://www. alz. co. uk/research/files/WorldAlzheimerReport. pdf. Accessed October 27, 2014.
2. Petrovic M, Hurt C, Collins D, et al. Clustering of behavioural and psychological symptoms in dementia (BPSD): a European Alzheimer's Disease Consortium (EADC) study. Acta Clin Belg. 2007; 62: 426-432.
3. Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry. 2000; 157: 708-714.
4. Aguero-Torres H, Von Strauss E, Viitanen M, Winblad B, Fratiglioni L. Institutionalization in the elderly: the role of chronic diseases and dementia. Cross-sectional and longitudinal data from a population-based study. J Clin Epidemiol. 2001; 54: 795-801.
5. Azermai M, Petrovic M, Elseviers MM, Bourgeois J, Van Bortel LM, Vander Stichele RH. Systematic appraisal of dementia guidelines on the management of behavioural and psychological symptoms. Ageing Res Rev. 2012; 11: 78-86.
6. Kroes M, Garcia-Stewart S, Allen F, Eyssen M, Paulus D. Dementie: welke niet-pharmacologische interventies? Good Clinical Practice. Brussels, Belgium: Federaal Kenniscentrum voor de Gezondheidszorg. 2011. KCE Reports 160A. Available from: http://kce. fgov. be/sites/default/files/page_documents/kce_160a_dementie. pdf. Accessed February 23, 2015. Dutch.
7. Richter T, Meyer G, Mohler R, Kopke S. Psychosocial interventions for reducing antipsychotic medication in care home residents. Cochrane Database Syst Rev. 2012; 12: CD008634.
8. Fossey J, Masson S, Stafford J, Lawrence V, Corbett A, Ballard C. The disconnect between evidence and practice: a systematic review of person-centred interventions and training manuals for care home staff working with people with dementia. Int J Geriatr Psychiatry. 2014; 29: 797-807.
9. Testad I, Corbett A, Aarsland D, et al. The value of personalized psychosocial interventions to address behavioral and psychological symptoms in people with dementia living in care home settings: a systematic review. Int Psychogeriatrics. 2014; 24: 1-16.
10. Whitaker R, Fossey J, Ballard C, et al. Improving Well-being and Health for People with Dementia (WHELD): study protocol for a randomised controlled trial. Trials. 2014; 15: 284.
11. Rolland Y, Andrieu S, Crochard A, Goni S, Hein C, Vellas B. Psychotropic drug consumption at admission and discharge of nursing home residents. J Am Med Dir Assoc. 2012; 13: 407. e7-e12.
12. Kamble P, Chen H, Sherer JT, Aparasu RR. Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data. Drugs Aging. 2009; 26: 483-492.
13. Mann E, Kopke S, Haastert B, Pitkala K, Meyer G. Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatr. 2009; 9: 18.
14. Schneider LS, Dagerman K, Insel PS. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry. 2006; 14: 191-210.
15. Ballard C, Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Rev. 2006; 1: CD003476.
16. Schneider LS, Tariot PN, Dagerman KS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med. 2006; 355: 1525-1538.
17. Yury CA, Fisher JE. Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia. Psychother Psychosom. 2007; 76: 213-218.
18. Sultzer DL, Davis SM, Tariot PN, et al. Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial. Am J Psychiatry. 2008; 165: 844-854.
19. US Food and Drug Administration Public Health Advisory. Public Health Advisory: deaths with antipsychotics in elderly patients with behavioral disturbances. 2005. Available from: http://www. fda. gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm053171. Accessed February 16, 2015.
20. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005; 294: 1934-1943.
21. US Food and Drug Administration Public Health Advisory. Antipsychotics are not indicated for the treatment of dementia-related psychosis. 2008. Available from: http://www. fda. gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm124830. htm. Accessed October 26, 2012.
22. Banerjee S. Department of Health. The use of antipsychotic medication for people with dementia: time for action. A report for the Minister of State for Care Services. 2009. Available from: http://psychrights. org/research/Digest/NLPs/BanerjeeReportOnGeriatricNeurolepticUse. pdf. Accessed October 26, 2012.
23. Liperoti R, Onder G, Landi F, et al. All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study. J Clin Psychiatry. 2009; 70: 13.
24. Azermai M, Elseviers M, Petrovic M, van Bortel L, Stichele RV. Assessment of antipsychotic prescribing in Belgian nursing homes. Int Psychogeriatr. 2011; 23: 1-9.
25. Kleijer BC, van Marum RJ, Egberts AC, et al. The course of behavioral problems in elderly nursing home patients with dementia when treated with antipsychotics. Int Psychogeriatr. 2009; 21: 931-940.
26. Agency for Healthcare Research and Quality. Off-label use of atypical antipsychotics: an update. No 43. Rockville, MD, USA: Comparative Effectiveness Reviews; 2011. Available from: http://www. ncbi. nlm. nih. gov/books/NBK66081/. Accessed October 26, 2014.
27. Azermai M, Vander Stichele RH, Van Bortel L, Elseviers M. Barriers to antipsychotic discontinuation in nursing homes: an exploratory study. Aging Ment Health. 2014; 18: 346-353.
28. Kverno KS, Black BS, Nolan MT, Rabins PV. Research on treating neuropsychiatric symptoms of advanced dementia with non-pharmacological strategies, 1998-2008: a systematic literature review. Int Psychogeriatr. 2009; 21: 825-843.
29. Lonergan E, Luxenberg J, Colford J. Haloperidol for agitation in dementia. Cochrane Database Syst Rev. 2002; 2: CD002852.